Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Events

06 Jun 2016 - 09 Jun 2016
22 Jun 2016 - 24 Jun 2016
04 Jul 2016 - 06 Jul 2016

Cell Culture Market Fueled by Biologics and Stem Cell Research

By BiotechDaily International staff writers
Posted on 20 Nov 2012
Print article
Cell culture is becoming the next big thing in pharma research, as laboratories rush to meet demand for stem cell and biologics.

A new report published by healthcare market research company GBI Research (New York, NY, USA) examined cell cultures, which entails the isolation of plant or animal cells, for their growth in an artificial environment where conditions such as temperature and pressure are all controlled.

Manufacturing of biopharmaceuticals involves cell culture methods, and the growing trend for biologics will drive the demand for cell culture processing. Biopharmaceuticals are target-specific molecules that are less toxic and more effective than small molecular compounds, and are in high demand for the treatment of cancer, arthritis, and diabetes, attracting the focus of many major pharmaceutical companies.

Because of the novel method of development, biopharmaceutical products are not easy to be synthesized by generic forms. R&D in the sector is principally focused on developing innovative processes of action, and increasing availability to newer treatments to produce potential cures and improve the quality of life for individuals suffering from various disorders. This focus helps in generating better treatment alternatives and earning larger profits for pharmaceutical and biotechnologic companies. The development and manufacturing of these biologic products is directly related to the growing demand for cell culture.

Stem cell research also has tremendous possibilities for cell culture applications. Cell culture techniques offer standardized production and propagation of highly purified stem cells and their differentiated progeny. Traditional therapies manage the disease symptoms, whereas stem cell therapies treat the root of the disorder, and from a commercial standpoint, this lack of effective treatments in established therapies makes stem cell research a potential goldmine. In the past few years, stem cell research has gained more clout in the cancer research arena, although the technique still faces many unresolved risks including the transmission of infectious agents and the uncontrolled proliferation of transplanted cells.

The cell culture market has more than 90% of its products manufactured by a small number of players, including Sigma-Aldrich Corp., EMD Millipore, Life Technologies Corp., and Thermo Fisher Scientific, Inc. A considerable number of small players are also entering into the market, particularly in emerging countries. However, rigid industry regulations restrict the pace at which these companies can advance. The cell culture process requires meticulous handling, with any changes affecting the safety and effectiveness of the final product. Consequently, the processes utilized for cell culturing are constrained by strict controls, which slow down development and act as a bottleneck to progression in cell culture processing techniques.

The global cell culture market was worth USD 3.4 billion in 2011, and it is expected to grow at a compound annual growth rate (CAGR) of 9.3% between 2011 and 2018 to reach USD 6.3 billion in 2018.

GBI Research is a provider of business intelligence reports, providing data and forecasts based on the insights of key industry leaders.

Related Links:

GBI Research




Print article

Channels

Genomics/Proteomics

view channel
Image: Follicular helper T-cells (TFH cells, shown in blue) play a crucial role in the maturation of antibody-producing B-cells (shown in green). Activated B-cells give rise germinal centers (shown in red), where mature B-cells proliferate and produce highly specific antibodies against pathogens. Top left: normal germinal center in a mouse tonsil. All others: Germinal centers fail to form when the interaction between ICOS and TBK1 is interrupted (Photo courtesy of Dr. Kok-Fai Kong, La Jolla Institute for Allergy and Immunology).

Molecular Pathway Controlling High-affinity Antibody Production Identified

A molecular pathway has been identified that controls formation of follicular helper T-cells (TFH cells) germinal centers and production of high-affinity antibodies through interaction with the inducible... Read more

Drug Discovery

view channel

Experimental Small-Molecule Anticancer Drug Blocks RAS-binding Domains

The experimental small-molecule anticancer drug rigosertib was shown to block tumor growth by acting as an RAS-mimetic and interacting with the RAS binding domains of RAF kinases, resulting in their inability to bind to RAS, which inhibited the RAS-RAF-MEK pathway. Oncogenic activation of RAS genes due to point mutations... Read more

Biochemistry

view channel
Image: A space-filling model of the anticonvulsant drug carbamazepine (Photo courtesy of Wikimedia Commons).

Wastewater May Contaminate Crops with Potentially Dangerous Pharmaceuticals

Reclaimed wastewater used to irrigate crops is contaminated with pharmaceutical residues that can be detected in the urine of those who consumed such produce. Investigators at the Hebrew University... Read more

Lab Technologies

view channel

Huge Modifiable Biomedical Database to Be Available on the Wikidata Site

Genome researchers are exploiting the power of the open Internet community Wikipedia database to create a comprehensive resource for geneticists, molecular biologists, and other interested life scientists. While efficiency in generating scientific data improves almost daily, applying meaningful relationships between... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.